Pacira BioSciences Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: PCRX
Share price (10/7/26): $25.20
Market cap (10/7/26): $1.005 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from SC TO-C 96 pages Agreement and Plan of Merger by and Among: Pacira Biosciences, Inc., Viatris Inc., and Peach Purchaser Sub Inc. Dated as of October 8, 2026

from 8-K 95 pages Agreement and Plan of Merger by and Among: Pacira Biosciences, Inc., Viatris Inc., and Peach Purchaser Sub Inc. Dated as of October 8, 2026

from 10-Q 101 pages Stock and Asset Purchase Agreement Dated as of June 28, 2026 Among Zimmer, Inc., Pacira Biosciences, Inc., and Pacira Cryotech, Inc

from 8-K 130 pages Agreement and Plan of Merger by and Among: Flexion Therapeutics, Inc., Pacira Biosciences, Inc., and Oyster Acquisition Company Inc. Dated as of October 11, 2021

from 8-K 102 pages Confidential Treatment Has Been Requested for the Redacted Portions of This Exhibit. the Redactions Are Indicated With “[**]”. a Complete Version of This Exhibit Has Been Filed With the U.S. Securities and Exchange Commission. Agreement and Plan of Merger by and Among Pacira Pharmaceuticals, Inc. Ps Merger, Inc. Myoscience, Inc. and Fortis Advisors LLC, as the Securityholders’ Representative March 4, 2019